Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3413]

Stopping tyrosine kinase inhibitors in CML

Dr Johan Richter - Lund University, Sweden

Stopping tyrosine kinase inhibitors in CML ( Dr Johan Richter - Lund University, Sweden )

Evaluation of ibrutinib in treatment of CLL with 17p deletion

Dr Jeffrey Jones - OSU James Cancer Hospital, Columbus, USA

Evaluation of ibrutinib in treatment of CLL with 17p deletion ( Dr Jeffrey Jones - OSU James Cancer Hospital, Columbus, USA )

Nivolumab restores effective anti-tumour response in Hodgkin lymphoma

Dr Anas Younes - Memorial Sloan Kettering Cancer Centre, New York, USA

Nivolumab restores effective anti-tumour response in Hodgkin lymphoma ( Dr Anas Younes - Memorial Sloan Kettering Cancer Centre, New York, USA )

ASCO 2016: Current treatment approaches for advanced prostate cancer

Prof Przemyslaw Twardowski and Prof Gordon McVie

ASCO 2016: Current treatment approaches for advanced prostate cancer ( Prof Przemyslaw Twardowski and Prof Gordon McVie )

The value and strategy for incorporating biosimilars Into clinical practice

Dr Francisco Esteva - New York University, New York, USA

The value and strategy for incorporating biosimilars Into clinical practice ( Dr Francisco Esteva - New York University, New York, USA )

Checkpoint inhibitor therapy benefits advanced bladder cancer patients

Dr Arjun Vasant Balar - NYU Langone Medical Center, New York, USA

Checkpoint inhibitor therapy benefits advanced bladder cancer patients ( Dr Arjun Vasant Balar - NYU Langone Medical Center, New York, USA )

Neuroblastoma outcomes improved with second stem cell transplant

Dr Julie Park - Seattle Children's Hospital, Seattle, USA

Neuroblastoma outcomes improved with second stem cell transplant ( Dr Julie Park - Seattle Children's Hospital, Seattle, USA )

Adjuvant docetaxel fails after radical prostatectomy for high risk prostate...

Dr Goran Ahlgren - Lund University, Malmö, Sweden

Adjuvant docetaxel fails after radical prostatectomy for high risk prostate cancer ( Dr Goran Ahlgren - Lund University, Malmö, Sweden )

Consolidative therapy extends PFS for NSCLC patients

Prof Daniel Richard Gomez - University of Texas MD Anderson Cancer Center...

Consolidative therapy extends PFS for NSCLC patients ( Prof Daniel Richard Gomez - University of Texas MD Anderson Cancer Center, Houston, USA )

Preliminary results from KEYNOTE-055: pembrolizumab in HNSCC

Dr Joshua Bauml - University of Pennsylvania, Philadelphia, USA

Preliminary results from KEYNOTE-055: pembrolizumab in HNSCC ( Dr Joshua Bauml - University of Pennsylvania, Philadelphia, USA )

Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma

Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, USA

Targetting PD-L1 with avelumab in metastatic Merkel cell carcinoma ( Dr Howard Kaufman - Rutgers Cancer Institute of New Jersey, USA )

Ten years of letrozole improves survival and quality of life in early-diagnosed...

Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada

Ten years of letrozole improves survival and quality of life in early-diagnosed breast cancer. ( Dr Julie Lemieux - Hôpital du Saint-Sacrement, Québec, Canada )

More from ecancer